Weill Cornell Medical College today opened the Belfer Research Building, a state-of-the-art facility that ushers in a new era at the institution for cutting-edge, translational science. The 18-story, $650 million building, made possible through the generosity of numerous donors, nearly doubles Weill Cornell’s existing research space and empowers scientists to rapidly translate groundbreaking discoveries into the most advanced patient care.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65415-weill-cornell-medical-college-belfer-cancer-research-building-opening
Bayer HealthCare’s Consumer Care division announced today the introduction of Bayer® Advanced Aspirin, the next generation of aspirin for pain relief. Using the patent-pending Pro-Release™ Technology, Bayer Advanced Aspirin is clinically proven to relieve tough pain twice as fast as previous Bayer® Aspirin tablets.
With the introduction of aspirin in 1899, Bayer offered one of the first widely accessible analgesics, or pain relievers, to consumers. Today, Bayer's overall global Aspirin business continues to grow, and had double-digit, year-on-year sales growth in Q1 2011. Yet, while Bayer continues to be a leader in the category, for many U.S. consumers, Bayer Aspirin is primarily synonymous with cardiovascular use. Now, through a combination of technological innovation and rich analgesic heritage, Bayer is introducing a new standard in aspirin for tough pain relief with Bayer Advanced Aspirin.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bayer/50414/
At the Mobile World Congress (MWC) exhibition starting today in Barcelona, B.I.S. Advanced Software Systems Ltd. will demonstrate our vast cloud storage capabilities to telecom industry ISPs/MSPs and large enterprises. With B.I.S.’s unique and innovative unified data access and mobility applications, you can generate customer stickiness, increased loyalty, and future profits and better ROI.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65012-BIS-mobile-world-congress-2014-cloud-storage
BioniX Wallpaper Changer is not only a wallpaper changer but also an advanced wallpaper manager: with BioniX you can easily move wallpapers to user-defined categories, filter small files that are unsuitable as wallpapers, sort wallpapers by file size/resolution/name/rating, move wallpapers to Recycle Bin, rename wallpaper, photo edit wallpapers, etc. It supports multiple/thematic playlists. Adding wallpapers to playlist is as simple as drag & drop.
Download it from here: http://www.BioniXWallpaper.com/downloads/index.html
Check out the full list of features here: http://www.BioniXWallpaper.com/features/index.html
Sometimes, style and technology come together to create a product that is both beautiful and intelligent. Inspired by the all-new 2013 Lexus ES, which blends advanced technology and style, Lexus has curated eight start-up products that are currently seeking funding to move into production. Each product embodies the intersection of high-tech and high-style. The goal is to make four of those ideas a reality.
Beginning today and continuing each week for four weeks, the “Lexus Ignition” Facebook application will match up two products and ask the digital community to vote for its favorite. The winner of each week’s popular vote will receive up to $25,000 in funding from Lexus. In total, Lexus will provide up to $100,000 in funding to four fan favorites in the head-to-head competition built entirely upon the brand’s social media channels.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58199-introducing-lexus-ignition
Aurora Flight Sciences announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company the prime contract for Phase 2 of the Agency’s Vertical Takeoff and Landing Experimental Plane (VTOL X-Plane) program.
VTOL X-Plane seeks to develop a technology demonstrator that could:
• Achieve a top sustained flight speed of 300 kt-400 kt
• Raise aircraft hover efficiency from 60 percent to at least 75 percent
• Present a more favorable cruise lift-to-drag ratio of at least 10, up from 5-6
• Carry a useful load of at least 40 percent of the vehicle’s projected gross weight of 10,000-12,000 pounds
The Aurora team’s design for its unmanned aircraft, named LightningStrike, seeks to provide an approximately 50-percent increase in speed over existing VTOL aircraft designed for comparable mission applications.
To view the multimedia release go to:
http://www.multivu.com/players/English/7617851-aurora-flight-sciences-vtol-xplane-darpa/
Men and women are biologically different – and so are their skincare needs. This premise fueled the development of the Artistry® brand’s latest scientifically advanced skincare collection, Artistry® Men.
Artistry® scientists’ findings and expertise led to this customized collection, which targets men’s two primary skincare needs – oil control and hydration – to reveal healthier-, younger-looking skin in men of all ages and ethnicities.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72394510-amway-artistry-skincare-for-men/
The Amgen Foundation announced today that it will invest more than $4 million to support and strengthen the Amgen Biotech Experience program across the United States, Puerto Rico, United Kingdom and Ireland. The Amgen Biotech Experience includes an engaging series of labs that effectively bring biotechnology into classrooms. This new commitment will also strengthen the program’s alignment with the United States’ Next Generation Science Standards, which are focused on engaging students in more authentic science learning experiences. With the support of Education Development Center, Inc. (EDC), the global nonprofit leading the Amgen Biotech Experience Program Office, the investment is expected to empower 1,000 teachers who will reach more than 150,000 new students with the labs over the next two years.
“We are very excited to extend our commitment to the Amgen Biotech Experience, a program that began 25 years ago, with the intent to ignite a deep passion for innovation and scientific discovery in students,” said Robert A. Bradway, chairman and chief executive officer of Amgen. “This program, which provides advanced biotech curriculum and professional-grade lab equipment at no cost to schools, has opened countless students’ eyes to the world of biotechnology, fueling potential long term advancements to both medicine and society.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7414055-amgen-biotech-experience-grant/
Altimetrik, a business transformation and technology solutions company is unveiling advanced IoT solutions that are set to revolutionize the manufacturing industry.
Manufacturing industry is faced with the challenge of digitally connecting its assets with systems and people, engineering and acting upon the data on the floor to achieve predictive maintenance, precision monitoring & remote management. Altimetrik's Enterprise IoT capabilities make operational intelligence real by connecting machine data to newer business insights & driving meaningful outcomes. Altimetrik has made significant investments in creating IoT specific Research & Innovation Labs which’ve helped the company become a frontrunner in IoT consulting and execution. Altimetrik has been identified among leading IoT solution providers for manufacturing by IDC
Altimetrik is among the new breed of technology companies driving its business model based on the three global mega trends of modernization – Digital, Connected Solutions and Consumer Technologies.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7772051-altimetrik-future-of-enterprise-internet/
Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis.
The study involved 104 infants, children and young adults with advanced neuroblastoma, a cancer of the sympathetic nervous system. Investigators discovered the ATRX gene was mutated only in patients age 5 and older. The alterations occurred most often in patients age 12 and older. These older patients were also more likely than their younger counterparts to have a chronic form of neuroblastoma and die years after their disease is diagnosed.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52992-st-jude-pediatric-cancer-genome-project-neuroblastoma-research
Today at the North American International Auto Show, Kia Motors America (KMA) hosted the global debut of the all-new 2019 Forte which enters its third generation with a more sophisticated design and desirable features that transforms one of Kia’s best-selling vehicles into something more than a compact car meant for getting people from one point to another. Thanks to a number of improvements, Forte now offers drivers a higher level of comfort, fuel efficiency and advanced driver assistance technologies that are aimed to make the journey – whether a short commute or long haul – a more rewarding and decidedly upscale experience.
To view the multimedia release go to:
https://www.multivu.com/players/English/8246051-kia-2019-forte-north-american-international-auto-show/
In the United States for 2014, about 62,900 new thyroid cancer cases will be diagnosed. Medullary thyroid cancer – a rare form of cancer located in the thyroid gland at the base of the throat – represents only about three to four percent of all thyroid cancers. Of those cases, just one third will be locally advanced or metastatic disease. With Thyroid Cancer Awareness Month in full swing, AstraZeneca has launched the aMTCSupport.com online resource center to provide information and support specifically designed for people living with advanced medullary thyroid cancer (aMTC) and their loved ones.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7080731-astrazeneca-amtcsupport-resources-for-advanced-medullary-thyroid-cancer/
